Pfizer Pharmaceuticals

Pfizer's Paxlovid not included in China's national insurance

Chinese health care authorities declined to include Pfizer's COVID-19 treatment drug in a national reimbursement list that would have allowed patients to get it at a cheaper price throughout the country, saying it was too expensive.

Paxlovid, an oral medicine developed by New York-based drugmaker Pfizer, has been widely sought after in China since the country began phasing out its “zero-COVID” restrictions and a surge of infections started sweeping through the country. 

https://candorium.com/news/20230109150955557/pfizer-s-paxlovid-not-included-in-china-s-national-insurance?utm_source=reddit&utm_medium=social&utm_campaign=news_post_social&utm_term=daily_news&utm_content=news_post_kathi5